CN104498180B - 一种从南极磷虾油中提取高纯度磷脂的方法 - Google Patents
一种从南极磷虾油中提取高纯度磷脂的方法 Download PDFInfo
- Publication number
- CN104498180B CN104498180B CN201410801886.XA CN201410801886A CN104498180B CN 104498180 B CN104498180 B CN 104498180B CN 201410801886 A CN201410801886 A CN 201410801886A CN 104498180 B CN104498180 B CN 104498180B
- Authority
- CN
- China
- Prior art keywords
- ethanol
- antarctic krill
- low polar
- polar solvent
- extraction liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000003904 phospholipids Chemical class 0.000 title claims abstract description 39
- 229940106134 krill oil Drugs 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 112
- 238000000605 extraction Methods 0.000 claims abstract description 45
- 239000007788 liquid Substances 0.000 claims abstract description 39
- 239000002798 polar solvent Substances 0.000 claims abstract description 32
- 241000239366 Euphausiacea Species 0.000 claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 15
- 239000006166 lysate Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000013517 stratification Methods 0.000 claims abstract description 9
- 238000009834 vaporization Methods 0.000 claims abstract description 8
- 230000008016 vaporization Effects 0.000 claims abstract description 8
- 230000009514 concussion Effects 0.000 claims abstract description 7
- 239000003960 organic solvent Substances 0.000 claims abstract description 7
- 238000002481 ethanol extraction Methods 0.000 claims abstract description 6
- 239000011259 mixed solution Substances 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims description 19
- 239000003921 oil Substances 0.000 claims description 17
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 10
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 9
- 238000009833 condensation Methods 0.000 claims description 5
- 230000005494 condensation Effects 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 description 15
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 125000005456 glyceride group Chemical group 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000008347 soybean phospholipid Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000006193 liquid solution Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
- 229940067626 phosphatidylinositols Drugs 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000000203 Hyaline Membrane Disease Diseases 0.000 description 1
- 208000032571 Infant acute respiratory distress syndrome Diseases 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010028974 Neonatal respiratory distress syndrome Diseases 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000003580 lung surfactant Substances 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 201000002652 newborn respiratory distress syndrome Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
- C07F9/103—Extraction or purification by physical or chemical treatment of natural phosphatides; Preparation of compositions containing phosphatides of unknown structure
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410801886.XA CN104498180B (zh) | 2014-12-20 | 2014-12-20 | 一种从南极磷虾油中提取高纯度磷脂的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410801886.XA CN104498180B (zh) | 2014-12-20 | 2014-12-20 | 一种从南极磷虾油中提取高纯度磷脂的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104498180A CN104498180A (zh) | 2015-04-08 |
CN104498180B true CN104498180B (zh) | 2015-11-18 |
Family
ID=52939635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410801886.XA Active CN104498180B (zh) | 2014-12-20 | 2014-12-20 | 一种从南极磷虾油中提取高纯度磷脂的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104498180B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10328105B2 (en) | 2015-05-27 | 2019-06-25 | Rimfrost Technologies As | Flowable concentrated phospholipid krill oil composition |
US11352380B2 (en) * | 2017-03-31 | 2022-06-07 | Avoca Llc | Methods for the preparation of phospholipid enriched krill compositions |
CN109097190B (zh) * | 2018-08-31 | 2020-08-11 | 山东鲁华海洋生物科技有限公司 | 一种从磷虾油中富集磷脂的方法 |
CN109207247A (zh) * | 2018-09-25 | 2019-01-15 | 深圳先进技术研究院 | 南极磷虾油的制备方法、脱腥南极磷虾油及其应用、食品 |
CN110514776A (zh) * | 2019-09-03 | 2019-11-29 | 中国水产科学研究院黄海水产研究所 | 一种南极磷虾油中磷脂的检测方法 |
CN114304285A (zh) * | 2021-12-18 | 2022-04-12 | 青岛市远洋捕捞有限公司 | 一种南极磷虾油组合物及其应用 |
CN114533792A (zh) * | 2022-04-19 | 2022-05-27 | 康源领鲜(山东)海洋科技股份有限公司 | 一种解酒护肝组合物及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008060163A1 (en) * | 2006-11-16 | 2008-05-22 | Pronova Biopharma Norge As | Process for production of omega-3 rich marine phospholipids from krill |
CN102041166A (zh) * | 2011-01-20 | 2011-05-04 | 山东师范大学 | 从南极磷虾中提取高磷脂含量的虾油的方法 |
CN102559366A (zh) * | 2012-02-21 | 2012-07-11 | 山东师范大学 | 一种富含磷脂酰乙醇胺南极磷虾虾油的制备方法 |
CN102585994A (zh) * | 2012-02-21 | 2012-07-18 | 山东师范大学 | 一种制备高磷脂含量的南极磷虾虾油的方法 |
CN102746941A (zh) * | 2012-07-18 | 2012-10-24 | 山东师范大学 | 一种从南极磷虾中富集磷脂酰肌醇的方法 |
CN103320217A (zh) * | 2013-07-11 | 2013-09-25 | 日照海大博远海洋生物科技有限公司 | 一种从南极磷虾中提取富含磷脂的磷虾油的方法 |
CN103509047A (zh) * | 2012-06-22 | 2014-01-15 | 上海傲硕生物科技有限公司 | 一种南极磷虾来源的磷脂酰胆碱的提取工艺和磷脂酰丝氨酸的制备方法 |
-
2014
- 2014-12-20 CN CN201410801886.XA patent/CN104498180B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008060163A1 (en) * | 2006-11-16 | 2008-05-22 | Pronova Biopharma Norge As | Process for production of omega-3 rich marine phospholipids from krill |
CN102041166A (zh) * | 2011-01-20 | 2011-05-04 | 山东师范大学 | 从南极磷虾中提取高磷脂含量的虾油的方法 |
CN102559366A (zh) * | 2012-02-21 | 2012-07-11 | 山东师范大学 | 一种富含磷脂酰乙醇胺南极磷虾虾油的制备方法 |
CN102585994A (zh) * | 2012-02-21 | 2012-07-18 | 山东师范大学 | 一种制备高磷脂含量的南极磷虾虾油的方法 |
CN103509047A (zh) * | 2012-06-22 | 2014-01-15 | 上海傲硕生物科技有限公司 | 一种南极磷虾来源的磷脂酰胆碱的提取工艺和磷脂酰丝氨酸的制备方法 |
CN102746941A (zh) * | 2012-07-18 | 2012-10-24 | 山东师范大学 | 一种从南极磷虾中富集磷脂酰肌醇的方法 |
CN103320217A (zh) * | 2013-07-11 | 2013-09-25 | 日照海大博远海洋生物科技有限公司 | 一种从南极磷虾中提取富含磷脂的磷虾油的方法 |
Non-Patent Citations (2)
Title |
---|
南极磷虾油脂及其它成分的提取分离;惠欢庆;《大连理工大学硕士论文》;20121231;23-33 * |
南极磷虾磷脂酰胆碱的提纯;张潇予;《山东师范大学硕士论文》;20121231;20-28 * |
Also Published As
Publication number | Publication date |
---|---|
CN104498180A (zh) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104498180B (zh) | 一种从南极磷虾油中提取高纯度磷脂的方法 | |
US20220125808A1 (en) | Lipid compositions with high dha content | |
CN102041166B (zh) | 从南极磷虾中提取高磷脂含量的虾油的方法 | |
CN105287666B (zh) | 一种沙棘籽油的制备方法 | |
EP3666265A1 (en) | Improved complexes and compositions containing curcumin | |
KR20200128656A (ko) | 리소포스파티딜콜린 조성물 | |
CN104000244B (zh) | 一种南极磷虾油软胶囊及其制备方法 | |
CN107441217B (zh) | 一种富含α-亚麻酸的口服乳剂及其制备方法 | |
JP5443979B2 (ja) | 新規のロイコトリエン受容体アンタゴニスト | |
CN103224514A (zh) | 一种高纯度蛋黄卵磷脂的生产工艺 | |
EP1583433B1 (en) | Preparations containing polyunsaturated phospholipids, monoterpenes and tryptophan and/or phytol derivatives | |
KR20150055876A (ko) | 체지방 감소 또는 체중 감소를 위한 조성물 | |
TW200814987A (en) | Stable and bioavailable compositions of isomers of carotenoids for skin and hair | |
CN107105695A (zh) | 具有增强的抗氧化性的海洋卵磷脂制剂 | |
CN105682481A (zh) | 包含胆碱及其衍生物的组合物、其用途以及其制备方法 | |
US20120184760A1 (en) | Removal of monoglycerides from fatty acid concentrates | |
CN104739763B (zh) | 一种具有抗炎和抗血栓形成作用的静脉注射用脂肪乳剂及其制备方法和用途 | |
US20150110866A1 (en) | Complexes and compositions containing curcumin | |
CN1212843C (zh) | 蛋黄卵磷脂软胶囊及其生产工艺 | |
WO2017109897A1 (ja) | エーテル型グリセロリン脂質の製造方法 | |
JP4969989B2 (ja) | リン脂質組成物およびこれを含有する食品組成物、医薬品組成物、並びにその製造方法 | |
CN108366600A (zh) | 用于通过纤维素衍生物的等轴晶体网络制备和稳定具有ω-3的乳液的方法 | |
JP2007110904A (ja) | 有用リン脂質組成物を含む機能性素材及び機能性食品 | |
WO1998016233A1 (en) | Formulations containing phosphatidylethanolamine | |
CN118416114A (zh) | 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Song Inventor after: Leng Kailiang Inventor after: Zhao Xianyong Inventor after: Miao Junkui Inventor after: Liu Xiaofang Inventor after: Yan Shaopeng Inventor after: Liu Chao Inventor after: Zhao Xinpeng Inventor before: Wang Song Inventor before: Leng Kailiang Inventor before: Miao Junkui Inventor before: Liu Xiaofang Inventor before: Yan Shaopeng Inventor before: Liu Chao Inventor before: Zhao Xinpeng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG SONG LENG KAILIANG MIAO JUNKUI LIU XIAOFANG YAN SHAOPENG LIU CHAO ZHAO XINPENG TO: WANG SONG LENG KAILIANG ZHAO XIANYONG MIAO JUNKUI LIU XIAOFANG YAN SHAOPENG LIU CHAO ZHAO XINPENG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |